Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc and reminds investors of the December 8, 2025 deadline to seek the role of lead plaintiff in a federal securities class action against the company [2][5]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives violated federal securities laws by making false and misleading statements and failing to disclose critical information [5]. - Specific allegations include the sale of over-the-counter financial instruments to itself, inconsistencies in financial statements, and reliance issues regarding Marex's financial disclosures [5]. - A report from NINGI Research accused Marex of a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions to hide losses and inflate profits, including a fabricated receivable of $17 million and nearly $1 billion in concealed derivatives exposure [6][7]. Group 2: Impact on Stock and Legal Proceedings - Following the release of the NINGI Research report, Marex's stock dropped by 6.2%, closing at $35.31 on heavy trading volume [7]. - The role of the lead plaintiff is crucial as it involves directing and overseeing the litigation on behalf of the class, with any member able to move the court to serve as lead plaintiff [8].

Core Viewpoint - Marex Group plc is facing a class action securities lawsuit due to alleged securities fraud that occurred between May 16, 2024, and August 5, 2025, which has adversely affected investors [1][2] Group 1: Lawsuit Details - The lawsuit claims that the defendants made false statements and concealed information regarding the improper inflation of cash flow, revenues, assets, and profits in the Market Making segment through off-book intercompany transactions [2] - As a result of these actions, the positive statements made by the defendants about the Company's business and prospects were materially false and misleading [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 8, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record, having secured hundreds of millions of dollars for shareholders and being recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

Core Viewpoint - Marex Group plc is facing a class action securities lawsuit due to alleged securities fraud that inflated its financial metrics, impacting investor trust and potential recovery [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for investors affected by alleged securities fraud between May 16, 2024, and August 5, 2025 [1]. - Defendants are accused of making false statements and concealing the improper inflation of cash flow, revenues, assets, and profits through off-book intercompany transactions [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 8, 2025, to request appointment as lead plaintiff, although participation does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [4].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Marex Group plc regarding a class action lawsuit due to allegations of false statements and misleading information related to the company's financial performance [1][3]. Summary by Sections Class Action Details - The class period for the lawsuit is from May 16, 2024, to August 5, 2025 [3]. - Allegations include that Marex Group improperly inflated its cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [3]. Shareholder Actions - Shareholders are encouraged to register for the class action by December 8, 2025, to potentially be appointed as lead plaintiff [4]. - Registration allows shareholders to receive updates on the case through portfolio monitoring software [4]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies engage in responsible business practices and seeks recovery for investors affected by misleading statements [5].

Core Viewpoint - A class action lawsuit has been filed against Marex Group plc, alleging significant accounting irregularities and misleading disclosures that resulted in inflated profits and concealed losses [1][3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased Marex shares between May 16, 2024, and August 5, 2025 [1][2]. - Investors have until December 8, 2025, to seek appointment as lead plaintiff [2]. - The lawsuit follows a report from NINGI Research that accused Marex of engaging in a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions [3][4]. Group 2: Allegations and Financial Discrepancies - The report highlighted multi-million-dollar discrepancies in intercompany receivables and loans, including a fabricated $17 million receivable and a subsidiary's profits inflated by 150% [4]. - It was alleged that Marex concealed nearly $1 billion in off-balance-sheet derivatives exposure, which was used to generate non-cash trading profits [4]. Group 3: Market Reaction - Following the report's release, Marex's stock price dropped by $2.33, or 6.2%, closing at $35.31, indicating significant investor losses [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Marex Group plc regarding a class action lawsuit due to allegations of false statements and misleading information related to the company's financial performance [1][2]. Group 1: Allegations and Class Action Details - The class period for the lawsuit is from May 16, 2024, to August 5, 2025 [1]. - Allegations include that Marex Group improperly inflated its cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [1]. - The defendants' positive statements about the company's business and prospects were claimed to be materially false and misleading [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by December 8, 2025, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [2]. - Participation in the case incurs no cost or obligation for the shareholders [2]. Group 3: About The Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Viewpoint - A class action lawsuit has been filed against Marex Group plc, alleging securities fraud that affected shareholders between May 16, 2024, and August 5, 2025 [2]. Group 1: Lawsuit Details - The lawsuit claims that Marex Group plc made false statements and concealed information regarding the inflation of its cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [3]. - As a result of these actions, the positive statements made by the defendants about the company's business and prospects were materially false and misleading [3]. Group 2: Next Steps for Affected Shareholders - Shareholders who suffered losses during the specified timeframe are encouraged to seek information about their rights to recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP, a recognized securities litigation firm, has a strong track record in securing recoveries for shareholders and has been ranked among the top securities litigation firms in the United States for seven consecutive years [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by December 8, 2025 [1][3]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false and misleading statements, including selling over-the-counter financial instruments to itself and having inconsistencies in financial statements [3]. - Specific allegations include a multi-year accounting scheme involving off-balance-sheet entities, fictitious transactions, and misleading disclosures to hide losses and inflate profits, with examples such as a $17 million fabricated receivable and nearly $1 billion in concealed derivatives exposure [4]. - Following the release of a damaging report, Marex's stock dropped by 6.2%, closing at $35.31 on heavy trading volume [5]. Group 2: Legal Proceedings and Investor Actions - The lead plaintiff in the class action is the investor with the largest financial interest who directs the litigation on behalf of the class, with options for other members to either participate or remain absent [6]. - Faruqi & Faruqi encourages anyone with information regarding Marex's conduct, including whistleblowers and former employees, to come forward [7].

Core Viewpoint - Rosen Law Firm is encouraging investors of Marex Group plc to secure legal counsel before the December 8, 2025 deadline for a class action lawsuit related to securities purchased between May 16, 2024, and August 5, 2025 [2][3]. Group 1: Class Action Details - Investors who purchased Marex securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and potential lead plaintiffs must act by December 8, 2025 [4]. - The lawsuit alleges that Marex made materially false and misleading statements and failed to disclose critical information regarding its financial practices, leading to investor damages when the truth emerged [6]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [5]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [5]. - In 2019, the firm secured over $438 million for investors, showcasing its capability and experience in handling such cases [5].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Marex Group plc during the specified Class Period of the upcoming lead plaintiff deadline on December 8, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought Marex securities between May 16, 2024, and August 5, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the December 8, 2025 deadline [2]. Group 2: Legal Representation - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions for investors [3]. - The firm has been recognized for its leadership in securities class action settlements, achieving significant recoveries in previous years, including over $438 million in 2019 [3]. Group 3: Case Allegations - The lawsuit alleges that Marex made materially false and misleading statements, including selling over-the-counter financial instruments to itself and inconsistencies in financial statements between subsidiaries [4]. - As a result of these actions, Marex's financial statements were deemed unreliable, leading to misleading positive statements about the company's business and operations [4].